Analysis of Proteomic Biomarkers for Acute Interstitial Lung Disease (ILD) in Gefitinib-Treated Japanese Non-Small Cell Lung Cancer (NSCLC) Patients

被引：0
|
作者：
Nyberg, Fredrik [1 ,2 ]
Ogiwara, Atsushi [3 ,4 ]
Harbron, Chris G. [5 ]
Kawakami, Takao [3 ,4 ,6 ]
Komatsu, Yasuhiko [3 ,4 ]
Nishimura, Toshihide [3 ,4 ,6 ]
Marko-Varga, Gyorgy [7 ]
机构：
[1] AstraZeneca R&D, Epidemiol, Molndal, Sweden
[2] Karolinska Inst, Inst Env Med, Stockholm, Sweden
[3] Med ProteoScope Co Ltd, R&D Div, Tokyo, Japan
[4] Yokohama City Uni, Adv Med Res Ctr, Yokohama, Kanagawa, Japan
[5] AstraZeneca R&D, Discovery Stat, Alderley Pk, Cheshire, England
[6] Tokyo Med Uni, Dep Surg 1, Tokyo, Japan
[7] Lund Uni, Div Clin Prot Sci & Imaging, Biomed Ctr, Lund, Sweden
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2010年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
262
引用
收藏
页码：S112 / S113
页数：2
相关论文
共 50 条
  • [31] Gefitinib and celecoxib in patients with platinum refractory non-small cell lung cancer (NSCLC).
    Gadgeel, SM
    Shehadeh, NJ
    Ruckdeschel, JC
    Chaplen, RA
    Belzer, K
    Wozniak, A
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 639S - 639S
  • [32] Outcomes of curative-intent radiotherapy in non-small cell lung cancer (NSCLC) patients with chronic obstructive pulmonary disease (COPD) and interstitial lung disease (ILD)
    Tang, Celion
    Mistry, Hitesh
    Bayman, Neil
    Chan, Clara
    Cobben, David
    Faivre-Finn, Corinne
    Harris, Margaret
    Kennedy, Jason
    Pemberton, Laura
    Price, Gareth
    Sheikh, Hamid
    Woolf, David
    Coote, Joanna
    Salem, Ahmed
    RADIOTHERAPY AND ONCOLOGY, 2021, 160 : 78 - 81
  • [33] Inherited EGFR variants and survival in patients with non-small cell lung cancer (NSCLC) treated with gefitinib.
    Gregorc, V
    Hidalgo, M
    Spreafico, A
    Aondio, G
    Cusatis, G
    Marsh, S
    Steinberg, SM
    Ludovini, V
    Villa, E
    Sparreboom, A
    Baker, SD
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9079S - 9079S
  • [34] Potential clinical prognostic factors in non-small cell lung cancer (NSCLC) patients treated with gefitinib.
    Villaflor, VM
    Polowy, CR
    Coon, JS
    Leslie, WT
    Lukic, I
    Kanevsky, G
    Gale, M
    Stewart, I
    Bonomi, P
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 638S - 638S
  • [35] Proteomic analysis of non-small cell lung cancer tissue interstitial fluids
    Shaomin Li
    Rui Wang
    Mingxin Zhang
    Lina Wang
    Shaoli Cheng
    World Journal of Surgical Oncology, 11
  • [36] Proteomic analysis of non-small cell lung cancer tissue interstitial fluids
    Li, Shaomin
    Wang, Rui
    Zhang, Mingxin
    Wang, Lina
    Cheng, Shaoli
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2013, 11
  • [37] Potential clinical prognostic factors in non-small cell lung cancer (NSCLC) patients treated with Gefitinib (Iressa)
    Villaflor, VM
    Polowy, CR
    Coon, J
    Leslie, W
    Lukic, I
    Kanevsky, G
    Gale, M
    Stewart, I
    Bonomi, P
    LUNG CANCER, 2004, 46 : S62 - S62
  • [38] The impact of epidermal growth factor receptor gene status on gefitinib-treated Japanese patients with non-small-cell lung cancer
    Ichihara, Shuji
    Toyooka, Shinichi
    Fujiwara, Yoshiro
    Hotta, Katsuyuki
    Shigematsu, Hisayuki
    Tokumo, Masaki
    Soh, Junichi
    Asano, Hiroaki
    Ichimura, Kouichi
    Aoe, Keisuke
    Aoe, Motoi
    Kiura, Katsuyuki
    Shimizu, Kenji
    Date, Hiroshi
    Shimizu, Nobuyoshi
    INTERNATIONAL JOURNAL OF CANCER, 2007, 120 (06) : 1239 - 1247
  • [39] EVALUATION OF BIOMARKERS IN PATIENTS WITH NON-SMALL CELL LUNG-CANCER (NSCLC)
    FOEMMEL, RS
    ALEXANDER, NA
    HIRSHAUT, Y
    KATOPODIS, N
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1987, 28 : 182 - 182
  • [40] 18F-FDG uptake on positron emission tomography in gefitinib-treated non-small cell lung cancer patients
    Na, I.
    Byun, B.
    Kang, H.
    Cheon, G.
    Kim, C.
    Koh, J.
    Choe, D.
    Ryoo, B.
    Lim, S.
    Lee, J.
    Yang, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
12345